EcoDrugPlus

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSPLAG00000021667
Gene Symbol: ATP1B2
3 Cross references
203 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 2

Ensembl ID : ENSPLAG00000014695
Gene Symbol: ATP1B2
3 Cross references
174 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSPLAG00000003668
Gene Symbol: ATP1B3
3 Cross references
236 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSPLAG00000008546
Gene Symbol: ATR
3 Cross references
205 Possible Orthologues:

Axl Receptor Tyrosine Kinase

Ensembl ID : ENSPLAG00000004248
Gene Symbol: AXL
2 Cross references
187 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSPLAG00000005838
Gene Symbol: BRAF
3 Cross references
219 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSPLAG00000013120
Gene Symbol: BCL2
3 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSPLAG00000019679
Gene Symbol: BCL2L1
4 Cross references
216 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSPLAG00000007363
Gene Symbol: BCL2L10
3 Cross references
128 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPLAG00000012384
Gene Symbol: BCR
3 Cross references
196 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSPLAG00000015602
Gene Symbol: BCR
3 Cross references
205 Possible Orthologues:

Bdnf/nt-3 Growth Factors Receptor-Like

Ensembl ID : ENSPLAG00000004573
Gene Symbol: LOC106954505
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).